Factors influencing creatine kinase-MM concentrations in newborns and implications for newborn screening for Duchenne muscular dystrophy-Reference-Cited by-同舟云学术

Factors influencing creatine kinase-MM concentrations in newborns and implications for newborn screening for Duchenne muscular dystrophy

Published:2023-08 Issue: Volume:118 Page:110614
ISSN:0009-9120
Container-title:Clinical Biochemistry
language:en
Short-container-title:Clinical Biochemistry

Author:

Maloney Breanne,Park Sunju,Sowizral Mycroft,Brackett Isa,Moslehi Roxana^ORCID,Chung Wendy K.^ORCID,Gruber Dorota^ORCID,Brower Amy,Lloyd-Puryear Michele^ORCID,Caggana Michele,Tavakoli Norma P.^ORCID

Publisher

Elsevier BV

Subject

Clinical Biochemistry,General Medicine

Reference41 articles.

1. Evidence-based path to newborn screening for Duchenne muscular dystrophy;Mendell;Ann. Neurol.,2012

2. Duchenne muscular dystrophy;Duan;Nat. Rev. Dis. Primers.,2021

3. Duchenne muscular dystrophy: neonatal screening and prenatal diagnosis;Plauchu;Lancet,1989

4. Neonatal screening for Duchenne muscular dystrophy: a novel semiquantitative application of the bioluminescence test for creatine kinase in a pilot national program in Cyprus, Genet;Drousiotou;Test.,1998

5. Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK);Moat;Eur. J. Hum. Genet.,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020–2023);International Journal of Neonatal Screening;2024-05-23

3. Two years of newborn screening for Duchenne muscular dystrophy as a part of the statewide Early Check research program in North Carolina;Genetics in Medicine;2024-01

4. Clinical Scoring Tool for Diagnosis of Dystrophinopathies: Can the Tool Finish the Job?;Annals of Indian Academy of Neurology;2023-10-13